Assessing the most effective times of day to take urine tests among pregnant women
October 15, 2014
Dr. Mark Walker has published a paper in the Journal of Exposure Science and Environmental concerning the use of urine tests taken from women during pregnancy to analyze levels of phthalates and bisphenol A (BPA). BPA is thought to disrupt normal hormone levels and development in fetuses. Traditionally, studies have relied on single spot urine analyses to assess exposure; ignoring variability in concentrations throughout a day or over a longer period of time. Dr. Walker and his team compared BPA and phthalate metabolite results from urine samples collected at five different time points. Dr. Walker concluded that a more accurate way to estimate average exposure across a pregnancy is to do more than one measurement at different times of day, rather than a single spot measurement. Read the study.
About the Ottawa Hospital Research Institute
The Ottawa Hospital Research Institute (OHRI) is the research arm of The Ottawa Hospital and is an affiliated institute of the University of Ottawa, closely associated with the university’s Faculties of Medicine and Health Sciences. OHRI includes more than 1,700 scientists, clinical investigators, graduate students, postdoctoral fellows and staff conducting research to improve the understanding, prevention, diagnosis and treatment of human disease.
Communications and Public Relations
Ottawa Hospital Research Institute